|

Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer

RECRUITINGSponsored by Lund University
Actively Recruiting
SponsorLund University
Started2010-08
Est. completion2031-08
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02306096

Summary

This study evaluates the genomic profiles of breast cancer in a prospective and population-based manner. In the first phase, breast tumors are analyzed by whole transcriptome RNA-sequencing. Gene expression profiles, mutational profiles, and transcript isoform-level data will be analyzed in the context of patient information, clinicopathological variables, and outcome, with the purpose to develop new molecular diagnostic assays for breast cancer. Additional genome-scale RNA, DNA, and protein analyses will be performed in the future.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* suspicion or confirmed diagnosis of primary breast cancer
* signed informed consent

Exclusion Criteria:

* lack of signed informed consent

Conditions3

Breast CancerBreast NeoplasmsCancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.